BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nasser NJ, Sun K, Scanlon KM, Mishra MV, Molitoris JK. Administering Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer 1-6 Days Compared to More Than 14 Days after the Start of LHRH Agonist Is Associated with Better Clinical Outcomes Due to Androgen Flare. Cancers (Basel) 2022;14:864. [PMID: 35205611 DOI: 10.3390/cancers14040864] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Nasser NJ. Androgen Flare after LHRH Initiation Is the Side Effect That Makes Most of the Beneficial Effect When It Coincides with Radiation Therapy for Prostate Cancer. Cancers (Basel) 2022;14:1959. [PMID: 35454866 DOI: 10.3390/cancers14081959] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]